Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Developmental changes in NO bioavailability in fetal erythrocytes.

Harry Bard1, Ann M English, Karine Bellemin

  • 1Pediatric Department, University of Montreal, St Justine's Hospital Montreal, Quebec, Canada. harry.bard@umontreal.ca

Seminars in Perinatology
|November 30, 2004
PubMed
Summary

This study examined how nitric oxide (NO) availability changes in fetal red blood cells as a baby develops in the womb. Researchers measured levels of S-nitrosohemoglobin (HbSNO) and HbFe(II)NO in cord blood samples from newborns of different gestational ages. They found that HbSNO levels increase with gestational age, likely due to a decrease in fetal hemoglobin (HbF). HbFe(II)NO levels remained stable regardless of gestational age. The findings suggest that lower HbSNO levels in early development may help protect the fetal circulatory system from excessive NO release. The study highlights how hemoglobin composition influences NO regulation during fetal growth.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modeling CH<sub>3</sub>SOH-aromatic complexes to probe cysteine sulfenic acid-aromatic interactions in proteins.

Physical chemistry chemical physics : PCCP·2025
Same author

Modeling predicts facile release of nitrite but not nitric oxide from the thionitrate CH<sub>3</sub>SNO<sub>2</sub> with relevance to nitroglycerin bioactivation.

Scientific reports·2024
Same author

Structural determination and anticholinesterase assay of C-glycosidic ellagitannins from Lawsonia inermis leaves: A study supported by DFT calculations and molecular docking.

Fitoterapia·2022
Same author

Modeling Shows that Rotation about the Peroxide O-O Bond Assists Protein and Lipid Functional Groups in Discriminating between H<sub>2</sub>O<sub>2</sub> and H<sub>2</sub>O.

The journal of physical chemistry. B·2020
Same author

Sublethal Paraquat Confers Multidrug Tolerance in <i>Pseudomonas aeruginosa</i> by Inducing Superoxide Dismutase Activity and Lowering Envelope Permeability.

Frontiers in microbiology·2020
Same author

Quantifying Heme-Protein Maturation from Ratiometric Fluorescence Lifetime Measurements on the Single Fluorophore in Its GFP Fusion.

The journal of physical chemistry. A·2020

Area of Science:

  • Hemoglobin biochemistry within developmental physiology
  • Nitric oxide signaling in fetal oxygen transport
  • Erythrocyte function in perinatal medicine

Background:

The role of hemoglobin in regulating nitric oxide (NO) delivery remains poorly understood during fetal development. Prior research has shown that S-nitrosohemoglobin (HbSNO) may control NO bioavailability in hypoxic tissues. However, the developmental trajectory of HbSNO levels in fetal erythrocytes is not well established. It was already known that HbSNO forms at Cysbeta93 and may influence oxygen-dependent NO release. No prior work had resolved how gestational age affects HbSNO levels in cord blood. This gap motivated the current investigation into how HbSNO and HbFe(II)NO levels change with fetal development. The study aimed to clarify the relationship between HbSNO and fetal hemoglobin (HbF) concentrations. Understanding these dynamics could improve models of fetal oxygen delivery. This uncertainty drove the need for direct measurements of HbSNO in newborn cord blood.

Purpose Of The Study:

The study aimed to assess developmental changes in HbSNO and HbFe(II)NO levels in fetal erythrocytes. Researchers sought to determine how gestational age influences these compounds in cord blood. The specific problem addressed was the lack of data on NO bioavailability in fetal red cells. The motivation stemmed from the need to understand how HbF levels affect HbSNO formation. The study focused on newborns across a range of gestational ages. The goal was to establish correlations between HbSNO levels and HbF concentrations. This approach allowed for a direct analysis of fetal hemoglobin dynamics. The findings could clarify how NO regulation evolves during gestation.

Keywords:
fetal hemoglobinnitric oxide regulationerythrocyte functiongestational age effects

Frequently Asked Questions

HbSNO levels increase with gestational age due to decreasing fetal hemoglobin (HbF) levels (r2 = 0.46, P = 0.0005).

Chemiluminescence was used to measure HbSNO and HbFe(II)NO in cord blood samples.

HbF levels strongly correlate with HbSNO levels (r2 = 0.81, P < 0.0001), suggesting HbF inhibits HbSNO formation.

The authors propose that HbA levels influence HbSNO formation during later stages of fetal development.

HbFe(II)NO levels remained stable (mean 1.68+/-1.15 x 10(-5) mol/mol heme) across gestational ages.

Related Experiment Videos

Main Methods:

The study used cord blood samples from newborns across gestational ages 24 to 41 weeks. HbSNO and HbFe(II)NO levels were measured via chemiluminescence. HbF concentrations were determined using high-performance liquid chromatography. The sample included 11 preterm and 11 term infants. Researchers analyzed the relationship between HbSNO and gestational age. They also examined how HbF levels influenced HbSNO formation. Statistical correlations were calculated using regression analysis. The study design allowed for a direct comparison of HbSNO levels across developmental stages.

Main Results:

HbSNO levels ranged from 0.37 to 1.72 x 10(-5) mol/mol heme in cord blood samples. A significant positive correlation was observed between HbSNO and gestational age (r2 = 0.46, P = 0.0005). This correlation was driven by decreasing HbF levels (r2 = 0.81, P < 0.0001). HbFe(II)NO levels remained stable across gestational ages (mean 1.68+/-1.15 x 10(-5) mol/mol heme). HbSNO levels increased in later stages of fetal development. Lower HbSNO levels were observed in early gestation samples. The findings suggest that HbA levels influence HbSNO formation. These results indicate a developmental shift in NO bioavailability regulation.

Conclusions:

The study found that HbSNO levels in fetal erythrocytes increase with gestational age. This increase correlates with decreasing HbF levels and rising HbA concentrations. The authors propose that lower HbSNO levels in early development protect fetal circulation from excessive NO release. The findings suggest that HbA plays a key role in regulating HbSNO formation. The study supports the idea that NO bioavailability is developmentally regulated. The results may help explain how fetal oxygen delivery adapts during gestation. The authors suggest that these dynamics could influence fetal vascular function. These conclusions are based on observed correlations in cord blood samples.

Low HbSNO levels in early development may protect fetal circulation from excessive NO and O2 release.